Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
adult patients, \>=18 years of age;
HER2 positive breast cancer with locally recurrent or metastatic lesions;
eligible for chemotherapy;
baseline LVEF \>=50%.
You may not be if
previous chemotherapy for metastatic or locally recurrent breast cancer;
previous radiotherapy for metastatic breast cancer (except for metastatic bone pain relief);
other primary tumor within last 5 years, with the exception of basal or squamous skin cancer, or in situ cancer of the cervix;
clinically significant cardiovascular disease;
chronic daily treatment with aspirin (\>325mg/day) or clopidogrel (\>75mg/day).
Clareo Health | A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer.
